Skip to content
Biotechnology

Transforming Children’s Lives: DP World’s Aviv Clinics Dubai’s Revolutionary Youth Protocol

Aviv Clinics 3 mins read

DP World's Aviv Clinics Dubai’s Revolutionary Youth Protocol

DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) -- At DP World's Aviv Clinics Dubai, the world’s most advanced brain and body performance clinic, we understand the heartache parents feel when their child's development is hindered by conditions like cerebral palsy, autism spectrum disorder, traumatic brain injury, and other neurological conditions. Watching a child struggle without clear answers is a devastating experience for any parent. Our mission is to provide clarity and hope through our state-of-the-art youth protocol, a program dedicated to diagnosing and treating these conditions to help children reach their full potential.

The journey begins with our comprehensive youth assessment. This critical first step involves evaluating your child's cognitive and physical health with extensive testing conducted by our world-class physicians and medical professionals. The assessment includes a detailed medical history, cognitive and physical exams, blood tests and specialized assessments, like speech and occupational therapy, based on each child’s needs. We also perform advanced genetic testing and brain imaging using MRI technology to uncover the root causes of developmental delays.

Understanding and diagnosing your child's specific condition is fundamental to providing effective care. Our assessment addresses critical questions about causes and potential treatment outcomes for your child's development.

Once the assessment is complete, if your child is found suitable for the program, our clinical team formulates a personalized treatment plan based on the assessment testing results. Each child’s plan combines a unique hyperbaric oxygen therapy (HBOT) protocol, cognitive training, nutritional guidance, and physical, occupational and speech therapies. HBOT involves breathing pure oxygen in a pressurized chamber, boosting oxygen levels in the blood and tissue, which promotes healing, stimulates brain function and neuroplasticity. Cognitive training helps improve attention, social skills, and information processing, while our tailored nutritional plans ensure your child receives the essential nutrients needed for optimal health and healing. Physical, occupational and speech therapies enhance physical, sensory and communication skills and improve the overall clinical outcomes.

At DP World's Aviv Clinics Dubai, our holistic approach goes beyond treating symptoms; we focus on the cause of the symptoms to treat the whole child, aiming to improve their development, independence and overall quality of life. Our commitment is to support each child in achieving their full potential, aiming to provide families with the answers to the difficult questions, and manage expectations for treatment outcomes.

If your child is facing developmental issues and you’re looking for a clear diagnosis or answers to your questions, contact us today to learn about our youth assessment and treatment programs. As a child heals, the family heals. Together, we can help your child live their best life.

For media inquiries please contact
sydney.miranda@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5bd1bb6e-8e07-4cd1-b1a1-320332a505c2


Primary Logo

More from this category

  • Biotechnology
  • 17/10/2024
  • 06:08
Dementia Australia

Rejection of drug a blow for Australians living with Alzheimer’s disease

Dementia Australia is disappointed by the initial decision of the Therapeutic Goods Administration (TGA) to reject Lecanemab for use in Australia. Lecanemab is a disease modifying treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment. Developed by pharmaceutical company Eisai, Lecanemab works by removing amyloid plaques from the brain and in doing so slows cognitive decline associated with the disease. Lecanemab is currently approved for use in the UK, USA, Japan, China, South Korea, Hong Kong, United Arab Emirates and Israel. In July it was rejected by the European Medicines Agency, a decision that…

  • Biotechnology
  • 17/10/2024
  • 00:10
Athos Therapeutics

Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells

ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related to induced Treg anti-inflammatory activitiesNo serious adverse effects or dose limiting toxicities were observed at any dose level, and ATH-063 demonstrated favorable pharmacokinetics (PK) The data provides clinical verification for Athos' Proprietary AI2 (Artificial Intelligence for Autoimmune drug development) computational software platform which generated ATH-063 LOS ANGELES, CA / ACCESSWIRE / October 16, 2024 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, today…

  • Biotechnology
  • 16/10/2024
  • 21:10
Moolec Science SA

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here. "With USDA approval for our GE pea, Moolec…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.